Publications
Where expertise meets impact
Berry doesn’t just follow industry standards — we set them. Our team of award-winning statisticians, journal editors, and regulatory advisors leads the field in Bayesian and adaptive trial design. With research published in The New England Journal of Medicine, JAMA, and The Lancet, we’re driving innovation where it matters most.
Over 90% of our scientists published influential work this past year, advancing adaptive, Bayesian, and platform trial methodology. Our blend of academic rigor, regulatory insight, and real-world experience makes Berry a true authority in modern clinical trials.
Explore our most impactful peer-reviewed publications below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Alzheimer's Association
Neuroscience
Alzheimer's Disease
Two-period linear mixed effects models to analyze clinical trials with run-in data when the primary outcome is continuous: Applications to Alzheimer's disease
September 5, 2019
2019
DOI: 10.1016/j.trci.2019.07.007
Alzheimer's Association
Neuroscience
Alzheimer's Disease
ESTIMATING YEARS FROM CLINICAL SYMPTOM ONSET FOR SPORADIC ALZHEIMER DISEASE: HOW FAR ARE WE?
July 1, 2019
2019
DOI:10.1016/j.jalz.2019.06.4565
JAMA
Sepsis
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
May 19, 2019
2019
DOI: 10.1001/jama.2019.5791
BMC
Sepsis
The Vitamin C, Thiamine and Steroids in Sepsis (VICTAS) Protocol: a prospective, multi-center, double-blind, adaptive sample size, randomized, placebo-controlled, clinical trial
May 5, 2019
2019
DOI: 10.1186/s13063-019-3254-2
JAMA Network Open
Sepsis
Effect of Levocarnitine vs Placebo as an Adjunctive Treatment for Septic Shock: The Rapid Administration of Carnitine in Sepsis (RACE) Randomized Clinical Trial
December 7, 2018
2018
DOI: 10.1001/jamanetworkopen.2018.6076
Wiley Online Library
Rare Diseases
Bayesian model of disease progression in GNE myopathy
December 3, 2018
2018
DOI: 10.1002/sim.8050
American Heart Association Journal
Neuroscience
Stroke
Letter by Berry et al Regarding Article, "Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study"
October 24, 2018
2018
DOI: 10.1161/STROKEAHA.118.022198
Wiley Online Library
Neuroscience
Alzheimer's Disease
A novel cognitive disease progression model for clinical trials in autosomal-dominant Alzheimer's disease
May 14, 2018
2018
DOI: 10.1002/sim.7811
No results found.
There are no results with this criteria. Try changing your search.